Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
47
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Zeng Ling | Chief Legal Officer & Sec'y | 15 | $0 | $28.6K | 2021-12-28 |
| Ciappenelli Robert D. | Chief Strategy Officer | 25 | $0 | $1.11M | 2021-12-28 |
| Aradhye Shreeram | EVP & Chief Medical Officer | 15 | $0 | $44.1K | 2021-12-28 |
| Freed Martin I | Director | 18 | $0 | $0 | 2021-12-28 |
| Pagan Douglas W. | Chief Financial Officer | 15 | $0 | $0 | 2021-12-28 |
| GRAY PATRICK M. | Director | 12 | $0 | $0 | 2021-12-28 |
| Smith Cynthia | Director | 14 | $0 | $0 | 2021-12-28 |
| Weissman James B | EVP & Chief Operating Officer | 127 | $31.4K | $5.84M | 2021-12-28 |
| Brown Bob D | See Remarks | 140 | $0 | $8.92M | 2021-12-28 |
| Koppel Adam | Director, 10% Owner | 21 | $0 | $60.42M | 2021-12-28 |
| Doberstein Stephen K | Director | 12 | $0 | $0 | 2021-12-28 |
| FAMBROUGH DOUGLAS | President and CEO | 54 | $488.7K | $3.61M | 2021-12-28 |
| KOZIN MARC D | Director | 16 | $71.0K | $0 | 2021-12-28 |
| BUCHI J KEVIN | Director | 16 | $0 | $0 | 2021-12-28 |
| HOFFMAN STEPHEN J | Director, 10% Owner | 34 | $3.00M | $0 | 2021-12-28 |
| Paglia Regina M. | Chief Human Resources Officer | 64 | $0 | $3.62M | 2021-07-06 |
| Protopapas Anna | Director | 6 | $0 | $0 | 2021-06-03 |
| GREEN JOHN B | Chief Financial Officer | 32 | $0 | $2.89M | 2020-04-20 |
| ROSSKAMP RALF | Chief Medical Officer | 8 | $0 | $453.8K | 2020-01-08 |
| Kolchinsky Peter | Director, 10% Owner | 45 | $0 | $58.10M | 2019-12-02 |
| Bain Capital Life Sciences Partners, LP | Director, 10% Owner | 5 | $2.00M | $38.55M | 2019-11-19 |
| LANGER DENNIS | Director | 30 | $0 | $697.1K | 2019-06-20 |
| BCIP Life Sciences Associates, LP | 10% Owner | 1 | $0 | $20.00M | 2019-05-29 |
| Halak Brian K | Director, 10% Owner | 47 | $0 | $19.89M | 2018-11-06 |
| Wise Bart W | SVP, Legal Affairs | 1 | $0 | $0 | 2018-06-21 |
| MADDEN DAVID | Director | 12 | $112.5K | $0 | 2018-06-21 |
| Domain Partners VIII, L.P. | 10% Owner | 9 | $4.96M | $0 | 2017-12-18 |
| RA CAPITAL MANAGEMENT, LLC | 10% Owner | 5 | $15.00M | $0 | 2017-12-18 |
| BLAIR JAMES C | 10% Owner | 13 | $0 | $0 | 2017-12-18 |
| PEACOCK BRUCE | Director | 4 | $0 | $0 | 2017-07-18 |
| DP VIII Associates, L.P. | 10% Owner | 6 | $36.8K | $0 | 2017-04-11 |
| RA Capital Healthcare Fund LP | 10% Owner | 1 | $0 | $0 | 2017-04-11 |
| Ashburn Theodore | See Remarks | 4 | $0 | $0 | 2016-01-08 |
| Bhargava Pankaj | Chief Medical Officer | 3 | $0 | $0 | 2016-01-08 |
| Freund John Gordon | Other | 1 | $0 | $976.6K | 2015-02-20 |
| Dentzer James E | Chief Financial Officer | 2 | $0 | $0 | 2015-01-09 |
| Deerfield Special Situations Fund, L.P. | 10% Owner | 12 | $0 | $3.66M | 2014-11-25 |
| Deerfield Special Situations International Master Fund, L.P. | 10% Owner | 3 | $0 | $1.94M | 2014-11-07 |
| Deerfield Private Design Fund II, L.P. | 10% Owner | 13 | $0 | $1.28M | 2014-10-15 |
| Miles Vincent J | Director | 2 | $0 | $0 | 2014-06-18 |
| Brookside Capital Investors II, L.P. | 10% Owner | 8 | $0 | $29.17M | 2014-03-18 |
| Skyline Venture Management V, LLC | 10% Owner | 10 | $3.00M | $0 | 2014-02-04 |
| Flynn James E | 10% Owner | 12 | $15.00M | $0 | 2014-02-04 |
| SCHOEMAKER KATHLEEN K | 10% Owner | 10 | $0 | $0 | 2014-02-04 |
| DOVEY BRIAN H | 10% Owner | 10 | $0 | $0 | 2014-02-04 |
| VITULLO NICOLE | 10% Owner | 10 | $0 | $0 | 2014-02-04 |
| TREU JESSE I | 10% Owner | 10 | $0 | $0 | 2014-02-04 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Aradhye Shreeram | EVP & Chief Medical Officer | D To issuer deriv | 2021-12-28 | 2021-12-29 | 124,700 | — | $0 | 0 | SEC↗ |
| Aradhye Shreeram | EVP & Chief Medical Officer | D To issuer deriv | 2021-12-28 | 2021-12-29 | 51,070 | — | $0 | 0 | SEC↗ |
| Aradhye Shreeram | EVP & Chief Medical Officer | D To issuer deriv | 2021-12-28 | 2021-12-29 | 8,513 | — | $0 | 0 | SEC↗ |
| Aradhye Shreeram | EVP & Chief Medical Officer | D To issuer deriv | 2021-12-28 | 2021-12-29 | 21,075 | — | $0 | 0 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | D To issuer deriv | 2021-12-28 | 2021-12-29 | 75,000 | — | $0 | 0 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | D To issuer deriv | 2021-12-28 | 2021-12-29 | 105,000 | — | $0 | 0 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | D To issuer deriv | 2021-12-28 | 2021-12-29 | 68,100 | — | $0 | 0 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | D To issuer deriv | 2021-12-28 | 2021-12-29 | 121,300 | — | $0 | 0 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | D To issuer deriv | 2021-12-28 | 2021-12-29 | 165,050 | — | $0 | 0 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | D To issuer deriv | 2021-12-28 | 2021-12-29 | 180,000 | — | $0 | 0 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | D To issuer deriv | 2021-12-28 | 2021-12-29 | 25,950 | — | $0 | 0 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | D To issuer deriv | 2021-12-28 | 2021-12-29 | 11,325 | — | $0 | 0 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | D To issuer deriv | 2021-12-28 | 2021-12-29 | 85,000 | — | $0 | 0 | SEC↗ |
| BUCHI J KEVIN | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 8,000 | — | $0 | 0 | SEC↗ |
| BUCHI J KEVIN | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 3,333 | — | $0 | 0 | SEC↗ |
| BUCHI J KEVIN | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 25,000 | — | $0 | 0 | SEC↗ |
| BUCHI J KEVIN | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 33,000 | — | $0 | 0 | SEC↗ |
| BUCHI J KEVIN | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 21,000 | — | $0 | 0 | SEC↗ |
| BUCHI J KEVIN | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 15,000 | — | $0 | 0 | SEC↗ |
| Ciappenelli Robert D. | Chief Strategy Officer | D To issuer deriv | 2021-12-28 | 2021-12-29 | 270,000 | — | $0 | 0 | SEC↗ |
| Ciappenelli Robert D. | Chief Strategy Officer | D To issuer deriv | 2021-12-28 | 2021-12-29 | 76,144 | — | $0 | 0 | SEC↗ |
| Ciappenelli Robert D. | Chief Strategy Officer | D To issuer deriv | 2021-12-28 | 2021-12-29 | 61,500 | — | $0 | 0 | SEC↗ |
| Ciappenelli Robert D. | Chief Strategy Officer | D To issuer deriv | 2021-12-28 | 2021-12-29 | 17,325 | — | $0 | 0 | SEC↗ |
| Ciappenelli Robert D. | Chief Strategy Officer | D To issuer deriv | 2021-12-28 | 2021-12-29 | 10,275 | — | $0 | 0 | SEC↗ |
| Doberstein Stephen K | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 25,000 | — | $0 | 0 | SEC↗ |
| Doberstein Stephen K | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 3,333 | — | $0 | 0 | SEC↗ |
| Doberstein Stephen K | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 15,000 | — | $0 | 0 | SEC↗ |
| Doberstein Stephen K | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 15,000 | — | $0 | 0 | SEC↗ |
| FAMBROUGH DOUGLAS | Chief Executive Officer | D To issuer deriv | 2021-12-28 | 2021-12-29 | 247,700 | — | $0 | 0 | SEC↗ |
| FAMBROUGH DOUGLAS | Chief Executive Officer | D To issuer deriv | 2021-12-28 | 2021-12-29 | 250,000 | — | $0 | 0 | SEC↗ |
| FAMBROUGH DOUGLAS | Chief Executive Officer | D To issuer deriv | 2021-12-28 | 2021-12-29 | 225,000 | — | $0 | 0 | SEC↗ |
| FAMBROUGH DOUGLAS | Chief Executive Officer | D To issuer deriv | 2021-12-28 | 2021-12-29 | 200,000 | — | $0 | 0 | SEC↗ |
| FAMBROUGH DOUGLAS | Chief Executive Officer | D To issuer deriv | 2021-12-28 | 2021-12-29 | 200,000 | — | $0 | 0 | SEC↗ |
| FAMBROUGH DOUGLAS | Chief Executive Officer | D To issuer deriv | 2021-12-28 | 2021-12-29 | 71,900 | — | $0 | 0 | SEC↗ |
| FAMBROUGH DOUGLAS | Chief Executive Officer | D To issuer deriv | 2021-12-28 | 2021-12-29 | 505,000 | — | $0 | 0 | SEC↗ |
| FAMBROUGH DOUGLAS | Chief Executive Officer | D To issuer deriv | 2021-12-28 | 2021-12-29 | 255,000 | — | $0 | 0 | SEC↗ |
| FAMBROUGH DOUGLAS | Chief Executive Officer | D To issuer deriv | 2021-12-28 | 2021-12-29 | 225,000 | — | $0 | 0 | SEC↗ |
| FAMBROUGH DOUGLAS | Chief Executive Officer | D To issuer deriv | 2021-12-28 | 2021-12-29 | 55,055 | — | $0 | 0 | SEC↗ |
| FAMBROUGH DOUGLAS | Chief Executive Officer | D To issuer deriv | 2021-12-28 | 2021-12-29 | 281,250 | — | $0 | 0 | SEC↗ |
| FAMBROUGH DOUGLAS | Chief Executive Officer | D To issuer deriv | 2021-12-28 | 2021-12-29 | 191,330 | — | $0 | 0 | SEC↗ |
| FAMBROUGH DOUGLAS | Chief Executive Officer | D To issuer deriv | 2021-12-28 | 2021-12-29 | 41,250 | — | $0 | 0 | SEC↗ |
| FAMBROUGH DOUGLAS | Chief Executive Officer | D To issuer deriv | 2021-12-28 | 2021-12-29 | 59,850 | — | $0 | 0 | SEC↗ |
| Freed Martin I | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 25,000 | — | $0 | 0 | SEC↗ |
| Freed Martin I | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 3,333 | — | $0 | 0 | SEC↗ |
| Freed Martin I | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 15,000 | — | $0 | 0 | SEC↗ |
| Freed Martin I | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 15,000 | — | $0 | 0 | SEC↗ |
| Freed Martin I | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 25,000 | — | $0 | 0 | SEC↗ |
| Freed Martin I | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 25,000 | — | $0 | 0 | SEC↗ |
| Freed Martin I | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 25,000 | — | $0 | 0 | SEC↗ |
| GRAY PATRICK M. | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 15,000 | — | $0 | 0 | SEC↗ |
| GRAY PATRICK M. | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 15,000 | — | $0 | 0 | SEC↗ |
| GRAY PATRICK M. | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 3,333 | — | $0 | 0 | SEC↗ |
| GRAY PATRICK M. | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 25,000 | — | $0 | 0 | SEC↗ |
| HOFFMAN STEPHEN J | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 3,333 | — | $0 | 0 | SEC↗ |
| HOFFMAN STEPHEN J | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 25,000 | — | $0 | 0 | SEC↗ |
| HOFFMAN STEPHEN J | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 15,000 | — | $0 | 0 | SEC↗ |
| HOFFMAN STEPHEN J | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 25,000 | — | $0 | 0 | SEC↗ |
| HOFFMAN STEPHEN J | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 15,000 | — | $0 | 0 | SEC↗ |
| HOFFMAN STEPHEN J | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 25,000 | — | $0 | 0 | SEC↗ |
| HOFFMAN STEPHEN J | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 25,000 | — | $0 | 0 | SEC↗ |
| HOFFMAN STEPHEN J | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 15,000 | — | $0 | 0 | SEC↗ |
| HOFFMAN STEPHEN J | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 15,000 | — | $0 | 0 | SEC↗ |
| HOFFMAN STEPHEN J | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 15,000 | — | $0 | 0 | SEC↗ |
| KOZIN MARC D | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 25,000 | — | $0 | 0 | SEC↗ |
| KOZIN MARC D | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 3,333 | — | $0 | 0 | SEC↗ |
| KOZIN MARC D | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 25,000 | — | $0 | 0 | SEC↗ |
| KOZIN MARC D | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 15,000 | — | $0 | 0 | SEC↗ |
| KOZIN MARC D | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 15,000 | — | $0 | 0 | SEC↗ |
| Pagan Douglas W. | Chief Financial Officer | D To issuer deriv | 2021-12-28 | 2021-12-29 | 95,650 | — | $0 | 0 | SEC↗ |
| Pagan Douglas W. | Chief Financial Officer | D To issuer deriv | 2021-12-28 | 2021-12-29 | 36,900 | — | $0 | 0 | SEC↗ |
| Pagan Douglas W. | Chief Financial Officer | D To issuer deriv | 2021-12-28 | 2021-12-29 | 20,475 | — | $0 | 0 | SEC↗ |
| Pagan Douglas W. | Chief Financial Officer | D To issuer deriv | 2021-12-28 | 2021-12-29 | 6,150 | — | $0 | 0 | SEC↗ |
| Smith Cynthia | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 3,333 | — | $0 | 0 | SEC↗ |
| Smith Cynthia | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 25,000 | — | $0 | 0 | SEC↗ |
| Smith Cynthia | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 15,000 | — | $0 | 0 | SEC↗ |
| Smith Cynthia | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 25,000 | — | $0 | 0 | SEC↗ |
| Smith Cynthia | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 15,000 | — | $0 | 0 | SEC↗ |
| Weissman James B | Chief Operating Officer & EV | D To issuer deriv | 2021-12-28 | 2021-12-29 | 25,950 | — | $0 | 0 | SEC↗ |
| Weissman James B | Chief Operating Officer & EV | D To issuer deriv | 2021-12-28 | 2021-12-29 | 11,325 | — | $0 | 0 | SEC↗ |
| Weissman James B | Chief Operating Officer & EV | D To issuer deriv | 2021-12-28 | 2021-12-29 | 11,879 | — | $0 | 0 | SEC↗ |
| Weissman James B | Chief Operating Officer & EV | D To issuer deriv | 2021-12-28 | 2021-12-29 | 33,999 | — | $0 | 0 | SEC↗ |
| Weissman James B | Chief Operating Officer & EV | D To issuer deriv | 2021-12-28 | 2021-12-29 | 180,000 | — | $0 | 0 | SEC↗ |
| Weissman James B | Chief Operating Officer & EV | D To issuer deriv | 2021-12-28 | 2021-12-29 | 111,800 | — | $0 | 0 | SEC↗ |
| Weissman James B | Chief Operating Officer & EV | D To issuer deriv | 2021-12-28 | 2021-12-29 | 75,000 | — | $0 | 0 | SEC↗ |
| Weissman James B | Chief Operating Officer & EV | D To issuer deriv | 2021-12-28 | 2021-12-29 | 121,300 | — | $0 | 0 | SEC↗ |
| Weissman James B | Chief Operating Officer & EV | D To issuer deriv | 2021-12-28 | 2021-12-29 | 68,100 | — | $0 | 0 | SEC↗ |
| Weissman James B | Chief Operating Officer & EV | D To issuer deriv | 2021-12-28 | 2021-12-29 | 105,000 | — | $0 | 0 | SEC↗ |
| Zeng Ling | Chief Legal Officer & Sec'y | D To issuer deriv | 2021-12-28 | 2021-12-29 | 46,120 | — | $0 | 0 | SEC↗ |
| Zeng Ling | Chief Legal Officer & Sec'y | D To issuer deriv | 2021-12-28 | 2021-12-29 | 7,688 | — | $0 | 0 | SEC↗ |
| Zeng Ling | Chief Legal Officer & Sec'y | D To issuer deriv | 2021-12-28 | 2021-12-29 | 13,669 | — | $0 | 0 | SEC↗ |
| Zeng Ling | Chief Legal Officer & Sec'y | D To issuer deriv | 2021-12-28 | 2021-12-29 | 81,825 | — | $0 | 0 | SEC↗ |
| Koppel Adam | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 15,000 | — | $0 | 0 | SEC↗ |
| Koppel Adam | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 25,000 | — | $0 | 0 | SEC↗ |
| Koppel Adam | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 25,000 | — | $0 | 0 | SEC↗ |
| Koppel Adam | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 15,000 | — | $0 | 0 | SEC↗ |
| Koppel Adam | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 25,000 | — | $0 | 0 | SEC↗ |
| Koppel Adam | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 25,000 | — | $0 | 0 | SEC↗ |
| Koppel Adam | Director | D To issuer deriv | 2021-12-28 | 2021-12-29 | 3,333 | — | $0 | 0 | SEC↗ |
| Aradhye Shreeram | EVP & Chief Medical Officer | U Tender | 2021-12-28 | 2021-12-29 | 6,973 | $38.25 | $266.7K | 0 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | U Tender | 2021-12-28 | 2021-12-29 | 2,367 | $38.25 | $90.5K | 0 | SEC↗ |
| BUCHI J KEVIN | Director | U Tender | 2021-12-28 | 2021-12-29 | 4,666 | $38.25 | $178.5K | 0 | SEC↗ |
| Ciappenelli Robert D. | Chief Strategy Officer | U Tender | 2021-12-28 | 2021-12-29 | 14,813 | $38.25 | $566.6K | 0 | SEC↗ |
| Doberstein Stephen K | Director | U Tender | 2021-12-28 | 2021-12-29 | 3,333 | $38.25 | $127.5K | 0 | SEC↗ |
| FAMBROUGH DOUGLAS | Chief Executive Officer | D To issuer | 2021-12-28 | 2021-12-29 | 231,431 | $38.25 | $8.85M | 0 | SEC↗ |
| Freed Martin I | Director | U Tender | 2021-12-28 | 2021-12-29 | 3,333 | $38.25 | $127.5K | 0 | SEC↗ |
| GRAY PATRICK M. | Director | U Tender | 2021-12-28 | 2021-12-29 | 3,333 | $38.25 | $127.5K | 0 | SEC↗ |
| HOFFMAN STEPHEN J | Director | U Tender | 2021-12-28 | 2021-12-29 | 16,157 | $38.25 | $618.0K | 0 | SEC↗ |
| KOZIN MARC D | Director | D To issuer | 2021-12-28 | 2021-12-29 | 6,333 | $38.25 | $242.2K | 0 | SEC↗ |
| KOZIN MARC D | Director | D To issuer | 2021-12-28 | 2021-12-29 | 5,000 | $38.25 | $191.3K | 0 | SEC↗ |
| Pagan Douglas W. | Chief Financial Officer | U Tender | 2021-12-28 | 2021-12-29 | 7,775 | $38.25 | $297.4K | 0 | SEC↗ |
| Smith Cynthia | Director | U Tender | 2021-12-28 | 2021-12-29 | 3,333 | $38.25 | $127.5K | 0 | SEC↗ |
| Weissman James B | Chief Operating Officer & EV | U Tender | 2021-12-28 | 2021-12-29 | 18,100 | $38.25 | $692.3K | 0 | SEC↗ |
| Zeng Ling | Chief Legal Officer & Sec'y | U Tender | 2021-12-28 | 2021-12-29 | 5,032 | $38.25 | $192.5K | 0 | SEC↗ |
| Koppel Adam | Director | U Tender | 2021-12-28 | 2021-12-29 | 3,333 | $38.25 | $127.5K | 0 | SEC↗ |
| Koppel Adam | Director | U Tender | 2021-12-28 | 2021-12-29 | 3,080,237 | $38.25 | $117.82M | 0 | SEC↗ |
| Zeng Ling | Chief Legal Officer & Sec'y | M Exercise deriv | 2021-12-15 | 2021-12-17 | 2,562 | — | $0 | 7,688 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | M Exercise deriv | 2021-12-15 | 2021-12-17 | 3,775 | — | $0 | 11,325 | SEC↗ |
| FAMBROUGH DOUGLAS | Chief Executive Officer | M Exercise deriv | 2021-12-15 | 2021-12-17 | 13,750 | — | $0 | 41,250 | SEC↗ |
| Weissman James B | Chief Operating Officer & EV | M Exercise deriv | 2021-12-15 | 2021-12-17 | 3,775 | — | $0 | 11,325 | SEC↗ |
| Aradhye Shreeram | EVP & Chief Medical Officer | M Exercise deriv | 2021-12-15 | 2021-12-17 | 2,837 | — | $0 | 8,513 | SEC↗ |
| Ciappenelli Robert D. | Chief Strategy Officer | M Exercise deriv | 2021-12-15 | 2021-12-17 | 3,425 | — | $0 | 10,275 | SEC↗ |
| Pagan Douglas W. | Chief Financial Officer | M Exercise deriv | 2021-12-15 | 2021-12-17 | 2,050 | — | $0 | 6,150 | SEC↗ |
| Zeng Ling | Chief Legal Officer & Sec'y | M Exercise | 2021-12-15 | 2021-12-17 | 2,562 | — | $0 | 5,784 | SEC↗ |
| Zeng Ling | Chief Legal Officer & Sec'y | F Tax w/h | 2021-12-15 | 2021-12-17 | 752 | $38.05 | $28.6K | 5,032 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | M Exercise | 2021-12-15 | 2021-12-17 | 3,775 | — | $0 | 4,042 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | F Tax w/h | 2021-12-15 | 2021-12-17 | 1,675 | $38.05 | $63.7K | 2,367 | SEC↗ |
| FAMBROUGH DOUGLAS | Chief Executive Officer | F Tax w/h | 2021-12-15 | 2021-12-17 | 5,348 | $38.05 | $203.5K | 231,431 | SEC↗ |
| FAMBROUGH DOUGLAS | Chief Executive Officer | M Exercise | 2021-12-15 | 2021-12-17 | 13,750 | — | $0 | 236,779 | SEC↗ |
| Weissman James B | Chief Operating Officer & EV | F Tax w/h | 2021-12-15 | 2021-12-17 | 1,675 | $38.05 | $63.7K | 18,100 | SEC↗ |
| Weissman James B | Chief Operating Officer & EV | M Exercise | 2021-12-15 | 2021-12-17 | 3,775 | — | $0 | 19,775 | SEC↗ |
| Aradhye Shreeram | EVP & Chief Medical Officer | M Exercise | 2021-12-15 | 2021-12-17 | 2,837 | — | $0 | 7,806 | SEC↗ |
| Aradhye Shreeram | EVP & Chief Medical Officer | F Tax w/h | 2021-12-15 | 2021-12-17 | 833 | $38.05 | $31.7K | 6,973 | SEC↗ |
| Ciappenelli Robert D. | Chief Strategy Officer | M Exercise | 2021-12-15 | 2021-12-17 | 3,425 | — | $0 | 16,054 | SEC↗ |
| Ciappenelli Robert D. | Chief Strategy Officer | F Tax w/h | 2021-12-15 | 2021-12-17 | 1,241 | $38.05 | $47.2K | 14,813 | SEC↗ |
| Pagan Douglas W. | Chief Financial Officer | F Tax w/h | 2021-12-15 | 2021-12-17 | 602 | $38.05 | $22.9K | 7,775 | SEC↗ |
| Pagan Douglas W. | Chief Financial Officer | M Exercise | 2021-12-15 | 2021-12-17 | 2,050 | — | $0 | 8,377 | SEC↗ |
| Ciappenelli Robert D. | Chief Strategy Officer | M Exercise deriv | 2021-12-13 | 2021-12-14 | 8,856 | — | $0 | 76,144 | SEC↗ |
| Ciappenelli Robert D. | Chief Strategy Officer | M Exercise | 2021-12-13 | 2021-12-14 | 8,856 | $22.58 | $200.0K | 12,629 | SEC↗ |
| FAMBROUGH DOUGLAS | Chief Executive Officer | M Exercise deriv | 2021-12-10 | 2021-12-13 | 146,195 | — | $0 | 55,055 | SEC↗ |
| FAMBROUGH DOUGLAS | Chief Executive Officer | M Exercise deriv | 2021-12-10 | 2021-12-13 | 33,670 | — | $0 | 191,330 | SEC↗ |
| FAMBROUGH DOUGLAS | Chief Executive Officer | M Exercise | 2021-12-10 | 2021-12-13 | 33,670 | $2.97 | $100.0K | 76,834 | SEC↗ |
| FAMBROUGH DOUGLAS | Chief Executive Officer | M Exercise | 2021-12-10 | 2021-12-13 | 146,195 | $3.42 | $500.0K | 223,029 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | M Exercise deriv | 2021-11-18 | 2021-11-22 | 24,936 | — | $0 | 0 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | S Sale | 2021-11-18 | 2021-11-22 | 24,936 | $37.94 | $946.1K | 267 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | M Exercise | 2021-11-18 | 2021-11-22 | 24,936 | $3.42 | $85.3K | 25,203 | SEC↗ |
| Aradhye Shreeram | EVP & Chief Medical Officer | S Sale | 2021-09-17 | 2021-09-17 | 2,056 | $21.47 | $44.1K | 4,969 | SEC↗ |
| Zeng Ling | Chief Legal Officer & Sec'y | S Sale | 2021-09-17 | 2021-09-17 | 1,334 | $21.47 | $28.6K | 3,222 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | S Sale | 2021-09-17 | 2021-09-21 | 21,250 | $21.06 | $447.5K | 267 | SEC↗ |
| Aradhye Shreeram | EVP & Chief Medical Officer | M Exercise deriv | 2021-09-15 | 2021-09-17 | 7,025 | — | $0 | 21,075 | SEC↗ |
| Zeng Ling | Chief Legal Officer & Sec'y | M Exercise deriv | 2021-09-15 | 2021-09-17 | 4,556 | — | $0 | 13,669 | SEC↗ |
| Aradhye Shreeram | EVP & Chief Medical Officer | M Exercise | 2021-09-15 | 2021-09-17 | 7,025 | — | $0 | 7,025 | SEC↗ |
| Zeng Ling | Chief Legal Officer & Sec'y | M Exercise | 2021-09-15 | 2021-09-17 | 4,556 | — | $0 | 4,556 | SEC↗ |
| KOZIN MARC D | Director | P Buy | 2021-08-10 | 2021-08-10 | 3,000 | $23.66 | $71.0K | 6,333 | SEC↗ |
| FAMBROUGH DOUGLAS | President and CEO | P Buy | 2021-08-10 | 2021-08-10 | 5,000 | $22.10 | $110.5K | 43,164 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | M Exercise deriv | 2021-08-02 | 2021-08-03 | 8,312 | — | $0 | 24,936 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | S Sale | 2021-08-02 | 2021-08-03 | 8,312 | $37.38 | $310.7K | 21,517 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | M Exercise | 2021-08-02 | 2021-08-03 | 8,312 | $3.42 | $28.4K | 29,829 | SEC↗ |
| Weissman James B | Chief Operating Officer & EV | M Exercise deriv | 2021-07-06 | 2021-07-08 | 30,000 | — | $0 | 33,999 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | M Exercise deriv | 2021-07-06 | 2021-07-08 | 1,450 | — | $0 | 7,250 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | M Exercise deriv | 2021-07-06 | 2021-07-08 | 1,712 | — | $0 | 11,988 | SEC↗ |
| Weissman James B | Chief Operating Officer & EV | S Sale | 2021-07-06 | 2021-07-08 | 30,000 | $39.09 | $1.17M | 16,000 | SEC↗ |
| Weissman James B | Chief Operating Officer & EV | M Exercise | 2021-07-06 | 2021-07-08 | 30,000 | $9.09 | $272.7K | 46,000 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | M Exercise | 2021-07-06 | 2021-07-08 | 1,712 | — | $0 | 3,431 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | M Exercise | 2021-07-06 | 2021-07-08 | 1,450 | — | $0 | 1,719 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | F Tax w/h | 2021-07-06 | 2021-07-08 | 1,404 | $37.05 | $52.0K | 2,027 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | M Exercise deriv | 2021-07-01 | 2021-07-06 | 8,312 | — | $0 | 33,248 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | M Exercise | 2021-07-01 | 2021-07-06 | 8,312 | $3.42 | $28.4K | 29,829 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | S Sale | 2021-07-01 | 2021-07-06 | 7,246 | $37.30 | $270.3K | 22,583 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | S Sale | 2021-07-01 | 2021-07-06 | 1,066 | $37.85 | $40.3K | 21,517 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | M Exercise deriv | 2021-06-25 | 2021-06-29 | 1,000 | — | $0 | 49,221 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | M Exercise | 2021-06-25 | 2021-06-29 | 1,000 | $22.58 | $22.6K | 1,269 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | S Sale | 2021-06-25 | 2021-06-29 | 1,000 | $38.00 | $38.0K | 269 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | M Exercise deriv | 2021-06-22 | 2021-06-24 | 2,279 | — | $0 | 50,221 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | M Exercise deriv | 2021-06-22 | 2021-06-24 | 2,406 | — | $0 | 55,094 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | M Exercise deriv | 2021-06-22 | 2021-06-24 | 13,750 | — | $0 | 85,000 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | S Sale | 2021-06-22 | 2021-06-24 | 13,555 | $37.10 | $502.9K | 5,149 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | M Exercise | 2021-06-22 | 2021-06-24 | 2,406 | $24.05 | $57.9K | 18,704 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | M Exercise | 2021-06-22 | 2021-06-24 | 2,279 | $22.58 | $51.5K | 16,298 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | M Exercise | 2021-06-22 | 2021-06-24 | 13,750 | $12.93 | $177.8K | 14,019 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | S Sale | 2021-06-22 | 2021-06-24 | 4,880 | $36.71 | $179.1K | 269 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | M Exercise deriv | 2021-06-17 | 2021-06-22 | 4,664 | — | $0 | 98,750 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | M Exercise deriv | 2021-06-17 | 2021-06-22 | 4,000 | — | $0 | 57,500 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | M Exercise | 2021-06-17 | 2021-06-22 | 4,000 | $24.05 | $96.2K | 8,933 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | M Exercise | 2021-06-17 | 2021-06-22 | 4,664 | $12.93 | $60.3K | 4,933 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | S Sale | 2021-06-17 | 2021-06-22 | 8,664 | $35.79 | $310.1K | 269 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | M Exercise deriv | 2021-06-16 | 2021-06-17 | 20,000 | — | $0 | 103,414 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | M Exercise deriv | 2021-06-16 | 2021-06-17 | 1,564 | — | $0 | 5,261 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | M Exercise deriv | 2021-06-16 | 2021-06-17 | 10,000 | — | $0 | 52,500 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | M Exercise | 2021-06-16 | 2021-06-17 | 1,564 | $26.62 | $41.6K | 31,833 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | S Sale | 2021-06-16 | 2021-06-17 | 31,464 | $35.63 | $1.12M | 369 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | S Sale | 2021-06-16 | 2021-06-17 | 100 | $36.15 | $3.6K | 269 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | M Exercise | 2021-06-16 | 2021-06-17 | 20,000 | $12.93 | $258.6K | 20,269 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | M Exercise | 2021-06-16 | 2021-06-17 | 10,000 | $22.58 | $225.8K | 30,269 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | M Exercise deriv | 2021-06-15 | 2021-06-17 | 381 | — | $0 | 1,144 | SEC↗ |
| Pagan Douglas W. | Chief Financial Officer | M Exercise deriv | 2021-06-15 | 2021-06-17 | 6,825 | — | $0 | 20,475 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | M Exercise | 2021-06-15 | 2021-06-17 | 381 | — | $0 | 381 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | F Tax w/h | 2021-06-15 | 2021-06-17 | 112 | $35.74 | $4.0K | 269 | SEC↗ |
| Pagan Douglas W. | Chief Financial Officer | M Exercise | 2021-06-15 | 2021-06-17 | 6,825 | — | $0 | 7,764 | SEC↗ |
| Pagan Douglas W. | Chief Financial Officer | F Tax w/h | 2021-06-15 | 2021-06-17 | 2,004 | $35.74 | $71.6K | 5,760 | SEC↗ |
| Ciappenelli Robert D. | Chief Commercial Officer | M Exercise deriv | 2021-06-14 | 2021-06-15 | 20,000 | — | $0 | 270,000 | SEC↗ |
| Ciappenelli Robert D. | Chief Commercial Officer | M Exercise | 2021-06-14 | 2021-06-15 | 20,000 | $15.61 | $312.2K | 23,773 | SEC↗ |
| Ciappenelli Robert D. | Chief Commercial Officer | S Sale | 2021-06-14 | 2021-06-15 | 20,000 | $38.00 | $760.0K | 3,773 | SEC↗ |
| Ciappenelli Robert D. | Chief Commercial Officer | M Exercise deriv | 2021-06-11 | 2021-06-15 | 10,000 | — | $0 | 290,000 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | M Exercise deriv | 2021-06-11 | 2021-06-15 | 10,000 | — | $0 | 85,000 | SEC↗ |
| Ciappenelli Robert D. | Chief Commercial Officer | M Exercise | 2021-06-11 | 2021-06-15 | 10,000 | $15.61 | $156.1K | 13,773 | SEC↗ |
| Ciappenelli Robert D. | Chief Commercial Officer | S Sale | 2021-06-11 | 2021-06-15 | 10,000 | $35.00 | $350.0K | 3,773 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | M Exercise | 2021-06-11 | 2021-06-15 | 10,000 | $9.09 | $90.9K | 31,517 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | S Sale | 2021-06-11 | 2021-06-15 | 10,000 | $34.00 | $340.0K | 21,517 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | M Exercise deriv | 2021-06-07 | 2021-06-08 | 10,000 | — | $0 | 95,000 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | M Exercise | 2021-06-07 | 2021-06-08 | 10,000 | $9.09 | $90.9K | 31,517 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | S Sale | 2021-06-07 | 2021-06-08 | 10,000 | $33.00 | $330.0K | 21,517 | SEC↗ |
| Koppel Adam | Director | A Award deriv | 2021-06-03 | 2021-06-07 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Koppel Adam | Director | A Award deriv | 2021-06-03 | 2021-06-07 | 3,333 | — | $0 | 3,333 | SEC↗ |
| Koppel Adam | Director | M Exercise deriv | 2021-06-03 | 2021-06-07 | 3,333 | — | $0 | 0 | SEC↗ |
| Doberstein Stephen K | Director | A Award deriv | 2021-06-03 | 2021-06-07 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Doberstein Stephen K | Director | A Award deriv | 2021-06-03 | 2021-06-07 | 3,333 | — | $0 | 3,333 | SEC↗ |
| Doberstein Stephen K | Director | M Exercise deriv | 2021-06-03 | 2021-06-07 | 3,333 | — | $0 | 0 | SEC↗ |
| GRAY PATRICK M. | Director | A Award deriv | 2021-06-03 | 2021-06-07 | 3,333 | — | $0 | 3,333 | SEC↗ |
| GRAY PATRICK M. | Director | M Exercise deriv | 2021-06-03 | 2021-06-07 | 3,333 | — | $0 | 0 | SEC↗ |
| GRAY PATRICK M. | Director | A Award deriv | 2021-06-03 | 2021-06-07 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BUCHI J KEVIN | Director | A Award deriv | 2021-06-03 | 2021-06-07 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BUCHI J KEVIN | Director | A Award deriv | 2021-06-03 | 2021-06-07 | 3,333 | — | $0 | 3,333 | SEC↗ |
| BUCHI J KEVIN | Director | M Exercise deriv | 2021-06-03 | 2021-06-07 | 4,666 | — | $0 | 0 | SEC↗ |
| Protopapas Anna | Director | M Exercise deriv | 2021-06-03 | 2021-06-07 | 3,333 | — | $0 | 0 | SEC↗ |
| Freed Martin I | Director | A Award deriv | 2021-06-03 | 2021-06-07 | 3,333 | — | $0 | 3,333 | SEC↗ |
| Freed Martin I | Director | A Award deriv | 2021-06-03 | 2021-06-07 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Freed Martin I | Director | M Exercise deriv | 2021-06-03 | 2021-06-07 | 3,333 | — | $0 | 0 | SEC↗ |
| KOZIN MARC D | Director | M Exercise deriv | 2021-06-03 | 2021-06-07 | 3,333 | — | $0 | 0 | SEC↗ |
| KOZIN MARC D | Director | A Award deriv | 2021-06-03 | 2021-06-07 | 3,333 | — | $0 | 3,333 | SEC↗ |
| KOZIN MARC D | Director | A Award deriv | 2021-06-03 | 2021-06-07 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Smith Cynthia | Director | A Award deriv | 2021-06-03 | 2021-06-07 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Smith Cynthia | Director | M Exercise deriv | 2021-06-03 | 2021-06-07 | 3,333 | — | $0 | 0 | SEC↗ |
| Smith Cynthia | Director | A Award deriv | 2021-06-03 | 2021-06-07 | 3,333 | — | $0 | 3,333 | SEC↗ |
| HOFFMAN STEPHEN J | Director | A Award deriv | 2021-06-03 | 2021-06-07 | 15,000 | — | $0 | 15,000 | SEC↗ |
| HOFFMAN STEPHEN J | Director | A Award deriv | 2021-06-03 | 2021-06-07 | 3,333 | — | $0 | 3,333 | SEC↗ |
| HOFFMAN STEPHEN J | Director | M Exercise deriv | 2021-06-03 | 2021-06-07 | 3,333 | — | $0 | 0 | SEC↗ |
| Koppel Adam | Director | M Exercise | 2021-06-03 | 2021-06-07 | 3,333 | — | $0 | 3,333 | SEC↗ |
| Doberstein Stephen K | Director | M Exercise | 2021-06-03 | 2021-06-07 | 3,333 | — | $0 | 3,333 | SEC↗ |
| GRAY PATRICK M. | Director | M Exercise | 2021-06-03 | 2021-06-07 | 3,333 | — | $0 | 3,333 | SEC↗ |
| BUCHI J KEVIN | Director | M Exercise | 2021-06-03 | 2021-06-07 | 4,666 | — | $0 | 4,666 | SEC↗ |
| Protopapas Anna | Director | M Exercise | 2021-06-03 | 2021-06-07 | 3,333 | — | $0 | 3,333 | SEC↗ |
| Freed Martin I | Director | M Exercise | 2021-06-03 | 2021-06-07 | 3,333 | — | $0 | 3,333 | SEC↗ |
| KOZIN MARC D | Director | M Exercise | 2021-06-03 | 2021-06-07 | 3,333 | — | $0 | 3,333 | SEC↗ |
| Smith Cynthia | Director | M Exercise | 2021-06-03 | 2021-06-07 | 3,333 | — | $0 | 3,333 | SEC↗ |
| HOFFMAN STEPHEN J | Director | M Exercise | 2021-06-03 | 2021-06-07 | 3,333 | — | $0 | 29,071 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | M Exercise deriv | 2021-06-01 | 2021-06-03 | 8,312 | — | $0 | 41,560 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | M Exercise deriv | 2021-06-01 | 2021-06-03 | 4,431 | — | $0 | 123,414 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | S Sale | 2021-06-01 | 2021-06-03 | 342 | $32.02 | $11.0K | 21,517 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | S Sale | 2021-06-01 | 2021-06-03 | 7,970 | $30.88 | $246.1K | 21,859 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | M Exercise | 2021-06-01 | 2021-06-03 | 8,312 | $3.42 | $28.4K | 29,829 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | S Sale | 2021-06-01 | 2021-06-03 | 305 | $31.97 | $9.8K | 0 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | S Sale | 2021-06-01 | 2021-06-03 | 4,126 | $30.86 | $127.3K | 305 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | M Exercise | 2021-06-01 | 2021-06-03 | 4,431 | $12.93 | $57.3K | 4,431 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | M Exercise deriv | 2021-05-03 | 2021-05-05 | 8,312 | — | $0 | 49,872 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | M Exercise deriv | 2021-05-03 | 2021-05-05 | 4,431 | — | $0 | 127,845 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | M Exercise | 2021-05-03 | 2021-05-05 | 8,312 | $3.42 | $28.4K | 29,829 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | S Sale | 2021-05-03 | 2021-05-05 | 7,153 | $30.16 | $215.7K | 22,676 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | S Sale | 2021-05-03 | 2021-05-05 | 1,135 | $31.01 | $35.2K | 21,541 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | S Sale | 2021-05-03 | 2021-05-05 | 24 | $31.66 | $760 | 21,517 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | S Sale | 2021-05-03 | 2021-05-05 | 3,956 | $30.17 | $119.4K | 475 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | S Sale | 2021-05-03 | 2021-05-05 | 475 | $31.25 | $14.8K | 0 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | M Exercise | 2021-05-03 | 2021-05-05 | 4,431 | $12.93 | $57.3K | 4,431 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | M Exercise deriv | 2021-04-30 | 2021-05-03 | 10,000 | — | $0 | 105,000 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | S Sale | 2021-04-30 | 2021-05-03 | 10,000 | $32.00 | $320.0K | 21,517 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | M Exercise | 2021-04-30 | 2021-05-03 | 10,000 | $9.09 | $90.9K | 31,517 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | M Exercise deriv | 2021-04-29 | 2021-05-03 | 10,000 | — | $0 | 115,000 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | M Exercise | 2021-04-29 | 2021-05-03 | 10,000 | $9.09 | $90.9K | 31,517 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | S Sale | 2021-04-29 | 2021-05-03 | 10,000 | $31.00 | $310.0K | 21,517 | SEC↗ |
| Weissman James B | Chief Operating Officer & EV | S Sale | 2021-04-16 | 2021-04-20 | 4,904 | $29.99 | $147.1K | 16,000 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | M Exercise deriv | 2021-04-01 | 2021-04-05 | 4,431 | — | $0 | 132,276 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | M Exercise deriv | 2021-04-01 | 2021-04-05 | 8,312 | — | $0 | 58,184 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | M Exercise | 2021-04-01 | 2021-04-05 | 4,431 | $12.93 | $57.3K | 4,431 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | S Sale | 2021-04-01 | 2021-04-05 | 4,431 | $25.86 | $114.6K | 0 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | S Sale | 2021-04-01 | 2021-04-05 | 8,124 | $25.85 | $210.0K | 21,705 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | S Sale | 2021-04-01 | 2021-04-05 | 188 | $26.50 | $5.0K | 21,517 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | M Exercise | 2021-04-01 | 2021-04-05 | 8,312 | $3.42 | $28.4K | 29,829 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | M Exercise deriv | 2021-03-01 | 2021-04-05 | 8,312 | — | $0 | 66,496 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | M Exercise | 2021-03-01 | 2021-04-05 | 8,312 | $3.42 | $28.4K | 29,829 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | M Exercise deriv | 2021-03-01 | 2021-03-02 | 4,431 | — | $0 | 136,707 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | M Exercise deriv | 2021-03-01 | 2021-03-02 | 8,312 | — | $0 | 91,746 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | S Sale | 2021-03-01 | 2021-03-02 | 4,075 | $28.92 | $117.8K | 356 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | M Exercise | 2021-03-01 | 2021-03-02 | 4,431 | $12.93 | $57.3K | 4,431 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | S Sale | 2021-03-01 | 2021-03-02 | 356 | $29.47 | $10.5K | 0 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | M Exercise | 2021-03-01 | 2021-03-02 | 8,312 | $9.09 | $75.6K | 29,829 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | S Sale | 2021-03-01 | 2021-03-02 | 7,529 | $28.90 | $217.6K | 22,300 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | S Sale | 2021-03-01 | 2021-03-02 | 783 | $29.49 | $23.1K | 21,517 | SEC↗ |
| Weissman James B | Chief Operating Officer & EV | S Sale | 2021-02-05 | 2021-02-08 | 7,156 | $26.99 | $193.1K | 20,904 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | M Exercise deriv | 2021-02-03 | 2021-04-05 | 5,246 | — | $0 | 0 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | M Exercise deriv | 2021-02-03 | 2021-04-05 | 3,066 | — | $0 | 74,808 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | M Exercise | 2021-02-03 | 2021-04-05 | 5,246 | $2.97 | $15.6K | 29,829 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | M Exercise | 2021-02-03 | 2021-04-05 | 3,066 | $3.42 | $10.5K | 24,583 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | M Exercise deriv | 2021-02-03 | 2021-02-04 | 8,312 | — | $0 | 100,058 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | M Exercise | 2021-02-03 | 2021-02-04 | 8,312 | $9.09 | $75.6K | 29,829 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | S Sale | 2021-02-03 | 2021-02-04 | 8,312 | $25.00 | $207.8K | 21,517 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | M Exercise deriv | 2021-02-02 | 2021-02-04 | 4,431 | — | $0 | 141,138 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | M Exercise | 2021-02-02 | 2021-02-04 | 4,431 | $12.93 | $57.3K | 4,431 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | S Sale | 2021-02-02 | 2021-02-04 | 4,431 | $24.00 | $106.3K | 0 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | M Exercise deriv | 2021-01-25 | 2021-04-05 | 16,630 | — | $0 | 5,246 | SEC↗ |
| Brown Bob D | Chief Scientific Ofr., EVP R | M Exercise | 2021-01-25 | 2021-04-05 | 16,630 | $2.97 | $49.4K | 43,147 | SEC↗ |
| Paglia Regina M. | Chief Human Resources Office | M Exercise deriv | 2021-01-25 | 2021-01-27 | 4,431 | — | $0 | 145,569 | SEC↗ |